AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Short Interest Down 16.0% in April

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 1,134,617 shares, a decrease of 16.0% from the March 31st total of 1,350,304 shares. Approximately 4.1% of the company’s stock are sold short. Based on an average trading volume of 909,914 shares, the days-to-cover ratio is presently 1.2 days.

Hedge Funds Weigh In On AGF U.S. Market Neutral Anti-Beta Fund

Institutional investors and hedge funds have recently made changes to their positions in the business. Triumph Capital Management purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 3rd quarter valued at approximately $70,000. J.Safra Asset Management Corp boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 114.8% during the 3rd quarter. J.Safra Asset Management Corp now owns 7,401 shares of the company’s stock valued at $118,000 after buying an additional 3,955 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 7.4% during the 3rd quarter. IFP Advisors Inc now owns 22,864 shares of the company’s stock valued at $364,000 after buying an additional 1,582 shares during the last quarter. Worth Asset Management LLC purchased a new position in shares of AGF U.S. Market Neutral Anti-Beta Fund during the 4th quarter valued at approximately $364,000. Finally, Creative Financial Designs Inc. ADV boosted its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 2.5% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 224,292 shares of the company’s stock valued at $3,571,000 after buying an additional 5,487 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.5%

Shares of AGF U.S. Market Neutral Anti-Beta Fund stock traded down $0.06 on Friday, hitting $12.40. 213,911 shares of the company’s stock traded hands, compared to its average volume of 939,942. The stock has a market cap of $318.58 million, a P/E ratio of 17.67 and a beta of -0.57. The firm’s 50-day moving average is $13.61 and its 200 day moving average is $14.24. AGF U.S. Market Neutral Anti-Beta Fund has a 52-week low of $12.31 and a 52-week high of $20.07.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.